ArticleGastro hep advances2026
Impact of an Electronic Health Record Update on Appropriately Scheduled 5-Year Colorectal Cancer-Screening Colonoscopies at an Academic Medical Center.
Article in Gastro hep advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Prior studies have shown that colorectal cancer screening/surveillance colonoscopies are performed earlier than guideline-recommended intervals. We implemented an electronic health record (EHR)-based intervention to improve the proportion of appropriate 5-year colonoscopies that are scheduled at a tertiary academic medical center. Methods: This was a single-center pre-post study of patients with a primary care provider at our institution with an active EHR flag for 5-year screening/surveillance colonoscopy due in 2023. We first conducted a chart review of cases scheduled between April 2023 and July 2023 to evaluate indication and appropriateness for 5-year screening based on the US Multi-Society Task Force February 2020 guidelines. Starting at July 2023, if the case was guideline inappropriate, the EHR flag was revised to reflect updated guideline-based recommendations. The postimplementation phase was defined as between October 2023 and January 2024. Results: Of 17,313 cases scheduled in the 10-month period, 9831 were screening/surveillance colonoscopies. Of the total number of cases, 1746 (10.1%) had a 5-year return flag, with 555 patients in the preimplementation phase, 538 in the transition phase, and 653 in the postimplementation phase. In the preimplementation phase, 69.2% (384/555) were guideline inappropriate, whereas in the postimplementation phase, 56.5% (369/653) were nonguideline. There was a 10.9% increase in appropriately scheduled cases per week after implementation. Conclusion: This study highlights the effectiveness of an EHR intervention in improving adherence to colorectal cancer-screening protocols. The concomitant decrease in polyp-based guideline-inappropriate cases shows that the intervention reflected updates in polyp guidelines. However, continued efforts are needed to reduce the high proportion of nonguideline cases, to increase capacity for other indicated procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.